(Q81537128)

English

P16 immunoreactivity is an independent predictor of tumor progression in minimally invasive urothelial bladder carcinoma

scientific article published on 08 January 2005

Statements

P16 immunoreactivity is an independent predictor of tumor progression in minimally invasive urothelial bladder carcinoma (English)

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit